Saliva as a non-invasive matrix for assessing xenobiotic metabolites and metabolomes: implications for maternal health and preeclampsia

Abstract

Chemical exposure during prenatal development has significant implications for both maternal and child health. Compared to blood, saliva is a non-invasive and less resource-intensive, alternative. Given the temporal variability of xenobiotic metabolites (XM), repeated sampling is essential. Therefore, saliva offers a valuable tool for the longitudinal assessment of prenatal exposomes. Despite its potential, no studies have explored saliva for XM measurement. This study pioneered using saliva to assess XM detectability and investigate the associations between prenatal XM and endogenous metabolomes in pregnant women. Saliva samples were analysed using mass spectrometry from 80 pregnant women at 24–34 weeks gestation. Metabolomes and exposomes were annotated using the Human Metabolome and U.S. Environmental Protection Agency databases. Metabolome-XM associations were clustered using Glay community clustering. Linear regression models, adjusted for age, estimated associations between catecholamines and XMs. XM levels were validated in a cohort of women (n = 14) with and without preeclampsia. Our study identified 582 metabolomes and 125 XM in saliva, demonstrating its potential as a matrix for exposure measurement. After false discovery rate correction, 18 109 significant metabolome-XM associations were identified. Community clustering revealed 37 connected clusters, with the largest cluster (238 nodes) enriched in tyrosine and catecholamine metabolism. Food-contact-chemicals and food-additives were significantly associated with higher catecholamine and their metabolite levels. Subgroup analyses revealed higher concentrations of these chemicals in women with preeclampsia compared to healthy controls. This study demonstrates that saliva contains valuable molecular data for measuring exposomes. Food-related chemicals were associated with higher catecholamine levels, which may be relevant to the prevalence of hypertensive crises in pregnancy.

References

[1] DeBordDG, et al.. Use of the “Exposome” in the practice of epidemiology: a primer on -omic technologies. Am. J. Epidemiol., 2016, 184: 302-314

[2] FareedY, BraunD, FlaschM, GlobischD, WarthB. A broad, exposome-type evaluation of xenobiotic phase II biotransformation in human biofluids by LC-MS/MS. Exposome, 2022, 2osac008

[3] Singh, M., Mishra, R. C., Shah, I., Wadhwa, V. & Mor, V. Xenobiotics: sources, pathways, degradation, and risk associated with major emphasis on pharmaceutical compounds. In Xenobiotics in Urban Ecosystems: Sources, Distribution and Health Impacts (eds Singh R., Singh P., Tripathi S., Chandra K. K., Bhadouria R.) (Springer International Publishing, 2023).

[4] WatersMD, SelkirkJK, OldenK. The impact of new technologies on human population studies. Mutat. Res./Rev. Mutat. Res., 2003, 544: 349-360

[5] ArnoldSM, et al.. The use of biomonitoring data in exposure and human health risk assessment: benzene case study. Crit. Rev. Toxicol., 2013, 43: 119-153

[6] BessonneauV, PawliszynJ, RappaportSM. The saliva exposome for monitoring of individuals’ health trajectories. Environ. Health Perspect., 2017, 125077014

[7] MuellerDC, PillerM, NiessnerR, SchererM, SchererG. Untargeted metabolomic profiling in saliva of smokers and nonsmokers by a validated GC-TOF-MS Method. J. Proteome Res., 2014, 13: 1602-1613

[8] Heras-GonzálezL, et al.. Influence of BPA exposure, measured in saliva, on childhood weight. Front. Endocrinol., 2022, 131040583

[9] WrightML, StarkweatherAR, YorkTP. Mechanisms of the maternal exposome and implications for health outcomes. ANS Adv. Nurs. Sci., 2016, 39: E17-E30

[10] NeedhamLL, et al.. Partition of environmental chemicals between maternal and fetal blood and tissues. Environ. Sci. Technol., 2011, 45: 1121-1126

[11] SimonAK, HollanderGA, McMichaelA. Evolution of the immune system in humans from infancy to old age. Proc. Biol. Sci., 2015, 28220143085

[12] SoomroMH, et al.. Associations between the chemical exposome and pregnancy induced hypertension. Environ. Res., 2023, 237116838

[13] WuD-d, et al.. Increased adverse pregnancy outcomes associated with stage 1 hypertension in a low-risk cohort. Hypertension, 2020, 75: 772-780

[14] PearsonH. Meet the human metabolome. Nature, 2007, 4468

[15] WishartDS, et al.. HMDB 3.0-the human metabolome database in 2013. Nucleic Acids Res., 2013, 41: D801-D807

[16] YoshizawaJM, et al.. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin. Microbiol. Rev., 2013, 26: 781-791

[17] QiuS, et al.. Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal. Transduct. Target Ther., 2023, 8132

[18] Bessonneau, V., Pawliszyn, J., Rappaport, S. M. The saliva exposome for monitoring of individuals’ health trajectories. Environ. Health Perspect.125, 077014 (2017).

[19] SuG, KuchinskyA, MorrisJH, StatesDJ, MengF. GLay: community structure analysis of biological networks. Bioinformatics, 2010, 26: 3135-3137

[20] MaitreL, et al.. Multi-omics signatures of the human early life exposome. Nat. Commun., 2022, 137024

[21] HolzmanC, et al.. Maternal catecholamine levels in midpregnancy and risk of preterm delivery. Am. J. Epidemiol., 2009, 170: 1014-1024

[22] NatrajanPG, McGarrtgleHHG, LawrenceDM, LachelinGCL. Plasma noradrenaline and adrenaline levels in normal pregnancy and in pregnancy-induced hypertension. BJOG: Int. J. Obstet. Gynaecol., 1982, 89: 1041-1045

[23] WhitingMJ, DoogueMP. Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin. Biochem. Rev., 2009, 30: 3-17

[24] Lenders, J. W. M. & Eisenhofer, G. Normetanephrine and metanephrine☆. In Encyclopedia of Endocrine Diseases 2nd edn (eds Huhtaniemi, I. & Martini, L.) (Academic Press, 2017).

[25] TankAW, Lee WongD. Peripheral and central effects of circulating catecholamines. Compr. Physiol., 2015, 5: 1-15

[26] CyrM, et al.. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc. Natl. Acad. Sci. USA, 2003, 100: 11035-11040

[27] MunckeJ, et al.. Scientific challenges in the risk assessment of food contact materials. Environ. Health Perspect., 2017, 125095001

[28] AnderssonK, FuxeK, ToftgårdR, NilsenOG, EnerothP. Gustafsson JA. Toluene-induced activation of certain hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion. Toxicol. Lett., 1980, 5: 393-398

[29] RiegelAC, ZapataA, ShippenbergTS, FrenchED. The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology, 2007, 32: 1558-1569

[30] DonaldJM, HooperK, Hopenhayn-RichC. Reproductive and developmental toxicity of toluene: a review. Environ. Health Perspect., 1991, 94: 237-244

[31] Wax, P. M. Monoamine oxidase inhibitors. In Encyclopedia of Toxicology 3rd edn (eds Wexler, P) (Academic Press, 2014).

[32] CocciniT, RandineG, LiB, ManzoL, CostaLG. Effect of styrene on monoamine oxidase B activity in rat brain. J. Toxicol. Environ. Health A, 1999, 56: 59-68

[33] NaoiM, NagatsuT. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase. Life Sci., 1987, 40: 1075-1082

[34] Skalicka-WoźniakK, OrhanIE, CordellGA, NabaviSM, BudzyńskaB. Implication of coumarins towards central nervous system disorders. Pharmacol. Res., 2016, 103: 188-203

[35] ChenuF, MansariME, BlierP. Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area. Int. J. Neuropsychopharmacol., 2009, 12: 475-485

[36] Creeley, C. E. & Denton, L. K. Use of prescribed psychotropics during pregnancy: a systematic review of pregnancy, neonatal, and childhood outcomes. Brain Sci. 9, 235 (2019).

[37] OnaolapoAY, OnaolapoOJ. Food additives, food and the concept of ‘food addiction’: is stimulation of the brain reward circuit by food sufficient to trigger addiction?. Pathophysiology, 2018, 25: 263-276

[38] ProrokT, JanaM, PatelD, PahanK. Cinnamic acid protects the nigrostriatum in a mouse model of Parkinson’s disease via peroxisome proliferator-activated receptorα. Neurochem. Res., 2019, 44: 751-762

[39] DaubnerSC, LeT, WangS. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem. Biophys., 2011, 508: 1-12

[40] RangasamySB, et al.. Stimulation of dopamine production by sodium benzoate, a metabolite of cinnamon and a food additive. J. Alzheimers Dis. Rep., 2021, 5: 295-310

[41] ChanalJL, AudranM, SicardMT, BrileyM. Brain penetration of orally administered sodium pyroglutamate. J. Pharm. Pharmacol., 1988, 40: 584-585

[42] KulaginaNV, ZigmondMJ, MichaelAC. Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience, 2001, 102: 121-128

[43] Franco, R., Reyes-Resina, I. & Navarro, G. Dopamine in health and disease: much more than a neurotransmitter. Biomedicines9, 109 (2021).

[44] LendersJWM. Endocrine disorders in pregnancy: pheochromocytoma and pregnancy: a deceptive connection. Eur. J. Endocrinol., 2012, 166: 143-150

[45] KjeldsenSE, et al.. Increased arterial adrenaline is highly correlated to blood pressure and in vivo platelet function in pre-eclampsia. J. Hypertens. Suppl., 1985, 3: S93-S95

[46] OianP, KjeldsenSE, EideI, MaltauJM. Increased arterial catecholamines in pre-eclampsia. Acta Obstet. Gynecol. Scand., 1986, 65: 613-617

[47] KhatunS, et al.. Increased concentrations of plasma epinephrine and norepinephrine in patients with eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol., 1997, 74: 103-109

[48] BaxterLRJr., KellyRC, PeterJB, ListonEH, TouserkaniS. Urinary phenylacetate and response to methylphenidate. J. Psychiatr. Res., 1988, 22: 131-139

[49] NavazeshM. Methods for collecting saliva. Ann. N. Y Acad. Sci., 1993, 694: 72-77

[50] PapapanouPN, et al.. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J. Periodontol., 2018, 89: S173-s82

[51] WishartDS, et al.. HMDB 5.0: the Human Metabolome Database for 2022. Nucleic Acids Res., 2022, 50: D622-d31

[52] PangZ, et al.. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res., 2024, 52: W398-W406

[53] RabenMS, MatsuzakiF. Effect of purines on epinephrine-induced lipolysis in adipose tissue. J. Biol. Chem., 1966, 241: 4781-4786

[54] BlardiP, et al.. Plasma catecholamine levels after fluoxetine treatment in depressive patients. Neuropsychobiology, 2005, 51: 72-76

[55] SpenceJD, MunozC, HuffMW, TokmakjianS. Effect of amlodipine on hemodynamic and endocrine responses to mental stress. Am. J. Hypertension, 2000, 13: 518-522

[56] Barupal Dinesh, K. & Fiehn, O. Generating the blood exposome database using a comprehensive text mining and database fusion approach. Environ. Health Perspect. 127, 097008 (2019).

Funding

MOH | National Medical Research Council (NMRC)((CNIG20nov-0003)

SingHealth Foundation(AM/SU035/2020)

RIGHTS & PERMISSIONS

The Author(s)